Experts say the future of obesity treatment will extend far beyond GLP-1 drugs by combining medications with personalized therapies and advanced procedures. The arrival of GLP-1 medications such as semaglutide (Wegovy, Ozempic, Rybelsus) and tirzepatide (Mounjaro, Zepbound) has dramatically changed how obesity is treated. But while these drugs have produced impressive results, experts say they […]This is a curated summary.